Cardiol Therapeutics Inc. — Investor Relations & Filings

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company's primary focus is on developing novel therapeutic approaches for underserved cardiovascular conditions by targeting the underlying mechanisms of inflammation and fibrosis. Its clinical programs are concentrated on significant and debilitating heart diseases, including recurrent pericarditis, myocarditis, and specific forms of heart failure. By collaborating with international researchers and clinicians, Cardiol Therapeutics aims to advance its pipeline of drug candidates to improve outcomes for patients suffering from these progressive syndromes.